Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology by Guido KroemerOncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology by Guido Kroemer

Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology

EditorGuido Kroemer, Dominik Mumberg, Kector Keun

Hardcover | August 20, 2008

Pricing and Purchase Info

$245.95

Earn 1230 plum® points
Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

In 1920s, Otto Warburg described the phenomenon of 'aerobic glycolysis', the ability of tumour cells to convert glucose to lactate in the presence of normal oxygen conditions. Warburg's hypothesis of an altered metabolism in cancer cells found no immediate acceptance, though it was latter confirmed for most human tumours. With the advent of molecular biology the focus in tumour research has shifted towards the search for oncogenes. However, the interest in cancer molecular profiling eventually led to a renaissance of the Warburg effect trying to combine genetic alterations with effects on metabolism with the help of modern analytic technologies to rapidly analyze broad varieties of metabolites in various tissues and bodyfluids (metabonomics).
Title:Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour PhysiologyFormat:HardcoverDimensions:281 pagesPublished:August 20, 2008Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3540794778

ISBN - 13:9783540794776

Look for similar items by category:

Reviews

Table of Contents

Mitochondria and Cancer.- Role of Metabolic Stress Responses of Apoptosis and Autophagy in Tumor Suppression.- The Interplay Between MYC and HIF in the Warburg Effect.- Using Metabolomics to Monitor Anticancer Drugs.- Biomarker Discovery for Drug Development and Translational Medicine Using Metabonomics.- Pyruvate Kinase Type M2: A Key Regulator Within the Tumour Metabolome and a Tool for Metabolic Profiling of Tumours.- Molecular Imaging of Tumor Metabolism and Apoptosis.-Minimally Invasive Biomarkers for Therapy Monitoring.- Use of Metabolic Pathway Flux Information in Anti-Cancer Drug Design.- Cancer Diagnostics Using H-NMR-Based Metabonomics.- Exploiting the Potential of Metabonomics in Large Population Studies.- Defining Personal Nutrition and Metabolic Health Through Metabonomics.